Silvia Dambacher

Silvia Dambacher is an accomplished professional in the fields of oncology and cell therapy, currently serving as Associate Director of MPM Oncology & Cell Therapy at Gilead Sciences since May 2018. Prior to this role, Silvia worked as a Medical Science Manager in Oncology at Bristol-Myers Squibb starting in March 2015, and also gained experience in sales at Aptalis Pharma from January 2014 to February 2015. Earlier in Silvia's career, significant scientific expertise was developed as a Scientist at the Adolf Butenandt Institute, LMU Munich from February 2008 to August 2013. Silvia Dambacher holds a doctorate in Molecular Biology (Dr. rer. nat) from Ludwig-Maximilians-Universität München, earned in 2013, and a Diplom Ingenieur degree in Biotechnology from Hochschule Mannheim, completed in 2007.